期刊文献+

肾上腺髓质素对慢性肾衰竭及血液透析患者血压的影响

下载PDF
导出
摘要 肾上腺髓质素(adrenomedullin,ADM)是日本学者Kitamure等于1993年从人肾上腺嗜铬细胞瘤中分离纯化出一种由52个氨基酸组成的多肽。而应用免疫组织化学定位和杂交表明,肾脏是ADM分布较高的器官之一,其含量依次为嗜铬细胞瘤肾上腺〉肺〉肾脏〉脑皮质、小肠、心脏。ADM在肾脏功能调节中发挥重要作用,但随着肾衰竭进展至尿毒症血液透析时而成为毒素,属于中分子物质,血浆及组织ADM水平明显升高,而维持性低血压血液透析患者血浆及组织ADM水平更高,对血压影响及其机制。本文就该方面的内容予以综述。
作者 金领微 刘俊
出处 《中国血液净化》 2009年第2期92-95,共4页 Chinese Journal of Blood Purification
  • 相关文献

参考文献42

  • 1Kitamura K, kanguwa M, Kawamato M, et al. Adrenomedullin:h novel hypotensive peptide isolated from human pheochromocytoma[J]. Biochem Biopohys Res Commun, 1993, 192: 553- 560.
  • 2汪培华,赵春霞,林立,汪道文.内皮型一氧化氮合酶基因对果糖诱导高血压大鼠的降压效应[J].中华心血管病杂志,2003,31(4):289-292. 被引量:15
  • 3张丽丽,曹泽毅,李维敏.肾上腺髓质素与妊娠关系的研究进展[J].国外医学(妇产科学分册),2002,29(3):131-134. 被引量:5
  • 4Vanholder R, Smet RD, Glorieux, et al. Review on uremic toxins:Classification, concentration, and interindividual variability[J].Kidney International, 2003,63:1934-1943.
  • 5Ishimitsu T, Nishikimi T, Saito Y, et al. Plasma levels of adrenomedullin, a newly identified hypotensive peptide, in patients with hypertension and renal failure[J]. J Clin Invest, 1994,94:2158-2161.
  • 6Nishikimi T, Saito Y, Kitamura K, et al. Increased plasma levels of adrenomedullin in patients with heart failure [J].J Am Coll Cardiol, 1995; 26:1424-1431.
  • 7Ishihara T, Yokota N, Hisanaga S. Increased plasma levels of mature form of adrenomedullin in patients with chronic renal failare[J].Clin Nephrol, 1999,52:119-23.
  • 8刘泽军,魏宗德,李晚珍.原发性高血压早期肾损害肾内血流动力学改变和内皮素-1及肾上腺髓质素的相关性分析[J].中国医师杂志,2007,9(5):692-693. 被引量:3
  • 9ParkJB, Charbonneau F, Schiffrin EL. Correlation of endothelial faction in large and small arteries in human essential hypertension[J].Hypertens, 2001,19:415-420.
  • 10Cases A, Esforzado N, Yera M, et al. Increased adrenomedullin levels in hypertensive patients on maintenance hemodialysis [J].Nefrologia, 2000,20:424-430.

二级参考文献53

  • 1张昭馥,石湘芸,赵云涛,李明旭,李洪艳,刘仙娥,张伶,刘玉洁,郭文英.肾实质性高血压患者血浆肾上腺髓质素测定的初步分析[J].中华肾脏病杂志,1996,12(4):227-229. 被引量:6
  • 2Rees DD, Palmer RM, Moncada S. Role of endothelium-derived nitric oxide in the regulation of blood pressure. Proc Natl Acad Sic U S A,1989,86:3375-3378.
  • 3Kim HS, Krege JH, Kluckman KD, et al. Genetic control of blood pressure and the angiotensinogen locus. Proc Natl Acad Sci U S A, 1995,92:2735-2739.
  • 4Alexander MY, Brosnan MJ, Hamilton CA, et al. Gene transfer of endothelial nitric oxide synthase improve nitric oxide-dependent endothelial function in a hypertensive rat model. Cardiovasc Res, 1999,43:798-807.
  • 5Alexander MY, Brosnan MJ, Hamilton CA, et al. Gene transfer of endothelial nitric oxide synthase but not Cu/Zn superoxlde dismutase restores nitric oxide availability in the SHRSP. Cardiovasc Res, 2000,47:609-617.
  • 6Takami S, Wong ZY, Stebbing M, et al. Linkage analysis of endothelial nitric c0fide synthase gene with human blood pressure. J Hypertens, 1999,17 : 1431-1436.
  • 7Kato N, Sugiyama T, Morita H, et al. Lack of evidence for association between the endothelial nitric oxide synthase gene and hypertension. Hypertension, 1999,33:933 -936.
  • 8Burt VL, Whelton P, Roccella EJ. Prevalence of hypertension in the US adult population. Resutts horn the Third National Health and Nutrition Examination Survey. Hypertension, 1995,25 :305-313.
  • 9Hwang IS, Ho H, Hoffman BB , et al. Fructose-induced insulin resistance and hypertension in rats. Hypertension, 1987, 10: 512-516.
  • 10Thorbum AW, Storlien LH, Jenkins AB, et al. Fructcee-induced in vivo insulin resistance and elevated plasma triglyceride levels in rats. Am J Clin Nutr, 1989,49 : 1155-1163.

共引文献25

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部